Level of Accuracy Practically Achievable in Radiation Therapy. David Followill and RPC staff August 6, 2013

Similar documents
Data Collected During Audits for Clinical Trials. July 21, 2010 Geoffrey S. Ibbott, Ph.D. and RPC Staff

Assessing Heterogeneity Correction Algorithms Using the Radiological Physics Center Anthropomorphic Thorax Phantom

The RPC s Evaluation of Advanced Technologies. AAPM Refresher Course July 29, 2008 Geoffrey S. Ibbott, Ph.D. and RPC Staff

What Can Go Wrong in Radiation Treatment: Data from the RPC. Geoffrey S. Ibbott, Ph.D. and RPC Staff

QA for Clinical Dosimetry with Emphasis on Clinical Trials

An Independent Audit and Analysis of Small Field Dosimetry Quality Assurance. David Followill IROC Houston QA Center

SBRT Credentialing: Understanding the Process from Inquiry to Approval

Accuracy Requirements and Uncertainty Considerations in Radiation Therapy

The Accuracy of 3-D Inhomogeneity Photon Algorithms in Commercial Treatment Planning Systems using a Heterogeneous Lung Phantom

RPC s Credentialing Programs for Clinical Trials

EORTC Member Facility Questionnaire

Activity report from JCOG physics group

Plan-Specific Correction Factors for Small- Volume Ion Chamber Dosimetry in Modulated Treatments on a Varian Trilogy

INTRODUCTION. Material and Methods

IMRT QUESTIONNAIRE. Address: Physicist: Research Associate: Dosimetrist: Responsible Radiation Oncologist(s)

S. Derreumaux (IRSN) Accidents in radiation therapy in France: causes, consequences and lessons learned

Quality assurance in external radiotherapy

IAEA-CN THE ESTRO-EQUAL RESULTS FOR PHOTON AND ELECTRON BEAMS CHECKS IN EUROPEAN RADIOTHERAPY BEAMS*

Presented by: Rebecca M. Howell PhD, DABR, FAAPM. Results from Voluntary Independent External Peer Review of Beam Output

Reference Photon Dosimetry Data for the Siemens Primus Linear Accelerator: Preliminary Results for Depth Dose and Output Factor

Limits of Precision and Accuracy of Radiation Delivery Systems

Leila E. A. Nichol Royal Surrey County Hospital

BELdART-2: Moving towards safer radiotherapy. Steven Lelie 1,2, Wouter Schroeyers 1, Brigitte Reniers 1, Sonja Schreurs 1

Problems and Shortcomings of the RPC Remote Monitoring Program of Institutions Dosimetry Data

Introduction. Measurement of Secondary Radiation for Electron and Proton Accelerators. Introduction - Photons. Introduction - Neutrons.

Patient and Linac QA - present and the future

Independent Dose Verification for IMRT Using Monte Carlo. C-M M Charlie Ma, Ph.D. Department of Radiation Oncology FCCC, Philadelphia, PA 19111, USA

D DAVID PUBLISHING. Uncertainties of in vivo Dosimetry Using Semiconductors. I. Introduction. 2. Methodology

TLD as a tool for remote verification of output for radiotherapy beams: 25 years of experience

Implementing New Technologies for Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 4, NUMBER 4, FALL 2003

Verification of Advanced Radiotherapy Techniques

An anthropomorphic head phantom with a BANG polymer gel insert for dosimetric evaluation of IMRT treatment delivery

Out-of-field doses of CyberKnife in stereotactic radiotherapy of prostate cancer patients

Non-target dose from radiotherapy: Magnitude, Evaluation, and Impact. Stephen F. Kry, Ph.D., D.ABR.

NIH/NCI Varian Medical Systemss Philips HealthCare

Small field diode dosimetry

ARCCHECK: COMPREHENSIVE EVALUATION OF THE DIODE ARRAY PHANTOM - RULES OF THUMB FOR PHANTOM USE FOR QA. By Vibha Chaswal, Ph.D.

Heterogeneity Corrections in Clinical Trials

Lung Spine Phantom. Guidelines for Planning and Irradiating the IROC Spine Phantom. MARCH 2014

Dosisverifikation mit Delta 4 Discover während der Behandlung

Follow this and additional works at: Part of the Medicine and Health Sciences Commons

Guidelines for the use of inversely planned treatment techniques in Clinical Trials: IMRT, VMAT, TomoTherapy

Measurement of Dose to Implanted Cardiac Devices in Radiotherapy Patients

IROC Liver Phantom. Guidelines for Planning and Irradiating the IROC Liver Phantom. Revised July 2015

RADIATION ONCOLOGY RESIDENCY PROGRAM Competency Evaluation of Resident

The Journey of Cyberknife Commissioning

Clinical Implementation of SRS/SBRT

Traceability and absorbed dose standards for small fields, IMRT and helical tomotherapy

The bootstrap method to improve statistical analysis of dosimetric data for radiotherapy outcomes

Use of Bubble Detectors to Characterize Neutron Dose Distribution in a Radiotherapy Treatment Room used for IMRT treatments

Intensity Modulated Radiation Therapy: Dosimetric Aspects & Commissioning Strategies

Film-based dose validation of Monte Carlo algorithm for Cyberknife system with a CIRS thorax phantom

Overview of Advanced Techniques in Radiation Therapy

A review of RTTQA audit. Karen Venables

Learning Objectives. Clinically operating proton therapy facilities. Overview of Quality Assurance in Proton Therapy. Omar Zeidan

3D DOSIMETRY IN END-TO-END DOSIMETRY QA

8/2/2018. Disclosure. Online MR-IG-ART Dosimetry and Dose Accumulation

IROC Prostate Phantom. Guidelines for Planning and Treating the IROC IMRT Prostate Phantom. Revised March 2014

Disclosures. Clinical Implementation of SRS/SBRT. Overview. Anil Sethi, PhD. Speaker: BrainLAB Standard Imaging Research collaboration: RaySearch

IROC Head and Neck Phantom. Guidelines for Planning and Irradiating the IROC IMRT Phantom. Revised April 2014

Future upcoming technologies and what audit needs to address

SunCHECK Patient Comprehensive Patient QA

CHAPTER 5. STUDY OF ANGULAR RESPONSE OF asi 1000 EPID AND IMATRIXX 2-D ARRAY SYSTEM FOR IMRT PATIENT SPECIFIC QA

IROC Head and Neck Phantom. Guidelines for Planning and Irradiating the IROC IMRT Phantom. Revised MARCH 2014

4 Essentials of CK Physics 8/2/2012. SRS using the CyberKnife. Disclaimer/Conflict of Interest

Disclosure. Outline. Machine Overview. I have received honoraria from Accuray in the past. I have had travel expenses paid by Accuray in the past.

ABSTRACTS FOR RADIOTHERAPY STANDARDS USERS MEETING. 5 th June 2007

Application(s) of Alanine

AAPM Task Group 180 Image Guidance Doses Delivered During Radiotherapy: Quantification, Management, and Reduction

Much of what we will say

Commission, Ganakbari, Savar, Dhaka, Bangladesh

Credentialing for Clinical Trials -IGRT. Evidence Based Radiation Oncology. Levels of Clinical Evidence. Why Credentialing?

Prostate Phantom. Guidelines for Planning and Treating the IMRT Prostate Phantom. Revised March 2014

Eric E. Klein, Ph.D. Chair of TG-142

Hampton University Proton Therapy Institute

Introduction. Modalities used in imaging guidance. Flat panel detector. X-ray Imaging Dose to Patients in the Era of Image-Guided Radiation Therapy

M. J. Maryanski, Three Dimensional BANG Polymer Gel Dosimeters AAPM'99, CE Course

International Practice Accreditation

PGY-1. Resident Review Session Schedule

8/2/2018. Disclosures. In ICRU91: SRT = {SBRT/SABR, SRS}

EQUIVALENT DOSE FROM SECONDARY NEUTRONS AND SCATTER PHOTONS IN ADVANCE RADIATION THERAPY TECHNIQUES WITH 15 MV PHOTON BEAMS

Calibration of dosimeters for small mega voltage photon fields at ARPANSA

How accurately can we measure dose clinically? Accurate clinical dosimetry. Dosimetric accuracy requirement

Standardization of dosimetry practices for small and large animal irradiation in radiobiological studies

SRS/SBRT Errors and Causes

Small field dosimetry, an example of what a Medical Physicist does (& some more examples) A/PROF SCOTT CROWE MEDICAL PHYSICIST

A model for assessing VMAT pre-treatment verification systems and VMAT optimization algorithms

EVALUATION OF INTENSITY MODULATED RADIATION THERAPY (IMRT) DELIVERY ERROR DUE TO IMRT TREATMENT PLAN COMPLEXITY AND IMPROPERLY MATCHED DOSIMETRY DATA

Feasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment

doi: /j.ijrobp

Quality assurance and credentialing requirements for sites using inverse planned IMRT Techniques

Dosimetry of the Gamma Knife TM

Normal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCT

Risk of Secondary Fatal Malignancies from Hi-Art Tomotherapy

Standard calibration of ionization chambers used in radiation therapy dosimetry and evaluation of uncertainties

Abdulhamid Chaikh 1,2, Jacques Balosso 1,2. Introduction

MVCT Image. Robert Staton, PhD DABR. MD Anderson Cancer Center Orlando. ACMP Annual Meeting 2011

6/29/2012 WHAT IS IN THIS PRESENTATION? MANAGEMENT OF PRIMARY DEVICES INVESTIGATED MAJOR ISSUES WITH CARDIAC DEVICES AND FROM MED PHYS LISTSERVS

Monte Carlo for CyberKnife Incise TM MLC

Transcription:

Level of Accuracy Practically Achievable in Radiation Therapy David Followill and RPC staff August 6, 2013

Sources of Treatment Uncertainty Machine functioning Radiation dose determination Patient specific data for treatment planning Radiation dose calculation in the patient Transfer of treatment plan to treatment machine Day to day variation in the treatment (machine/patient motion/set up)

Modern Treatment Units 1. Modern units for a specific make/model/energy have nearly the same dosimetry parameters. 2. RPC measurements based standard data typically within 1-1.5% 3. QA methodology and equipment have come a long way. However this does not mean we can become lackadaisical in performing our QA

The RPC has spent the last 45 years trying to minimize the uncertainty in radiation dose delivery and improve the accuracy for the clinical trial participating institutions.

In water phantom reference calibrations indicates a spread in the machine output of ~2.5% for 95% of the data since TG-51 was implemented REFERENCE CALIBRATION PHOTON ELECTRON 2000-2006 output 1.004 0.991 2 std dev. ±0.026 ±0.022 2006-2013 output 1.004 1.017 2 std dev. ±0.026 ±0.024 Contributing factors 1. T & P 2. N d,w 3. P elec 4. cables 5. Depth 6. SSD 7. Field size 8. TG-51 factors 9. End effect 10. %dd correction 11. Human error

WARNING! I KNEW THEY WERE OFF BUT I THOUGHT IT WOULD ALL AVERAGE OUT.

Now one of the hottest topics output factors (OPF) Really no problem with OPFs 4 x 4 cm 2 - RPC data show 2σ = ~1% What about < 4 x 4 cm 2? Contributing factors 1. Chamber vol. 2. Cables 3. Field size 4. Depth 5. SSD 6. Human error From Das et al 2000

TG-155 Small Field Dosimetry Corrections Situation is even worse if you consider using field sizes less then 0.5 x 0.5 cm 2 Francescon et al 2011 data

The Problem is that our Dragon is very small!

Tables of standard small field factors Followill et al 2012 RPC: 0.8-2.4% Institution: 0.4 3.8% It s HARD!

Wedges Our nemesis yet they should be our friend! It s not a hard measurement, you just need to take the time to center your chamber accurately (<0.5% rdg change when wedge flipped) The RPC finds a wedge factor outside our ±2% criterion in a THIRD of the sites we visit.

Off Axis Factors can SURPRISE you Matched machines may have the same dosimetry data but their profiles may be quite different. Machine A Position RPC Institution + RPC/Inst. 5 cm left 1.036 1.024 1.01 10 cm left/right 1.060/1.065 1.040 1.02/1.02 10 cm toward/away 1.059/1.064 1.040 1.02/1.02 15 cm left 1.080 1.052 1.03* Machine B Position RPC Institution + RPC/Inst. 5 cm left 1.016 1.024 0.99 10 cm left/right 1.018/1.013 1.040 0.98/0.97* 10 cm toward/away 1.019/1.012 1.040 0.98/0.97* 15 cm left 1.016 1.052 0.97* OAD 2 σ 5 1.8% 10 2.4% 15 3.2%

On-Site Dosimetry Review Audit Discrepancies Discovered (Jan. 05 April 13) Discrepancies Regarding: Number of Institutions Receiving rec. (n = 206) Review QA Program 152 (74%) Photon Field Size Dependence 138 (67%) Wedge Factor (WF) 66 (32%) Off-axis Factors (OAF)/Beam symmetry 60 (29%) Electron Calibration 35 (17%) Photon Depth Dose 33 (16%) Electron Depth Dose 25 (12%) Photon Calibration 16 (8%)

Sort of Disturbing to the RT community when Das et al published their findings on variations between prescribed and planned doses. Das et al 2008

Clinical Trial Patient Case Rapid Review Rapid review (pre-treatment review) is designed to evaluate the plan prior to treatment to ensure it meets the protocol prescription specifications. 56 IMRT Gyne rapid reviews were performed in 2013 (to date) - 22 submitted twice (39%) - 6 submitted three times (11%) - 2 had to submit 4 times.

Sources of Treatment Uncertainty Machine functioning Radiation dose determination Patient specific data for treatment planning Radiation dose calculation in the patient Transfer of treatment plan to treatment machine Day to day variation in the treatment (machine/patient motion/set up)

Benefits of RPC Phantoms Independent end to end audit 1. Imaging 2. Planning/dose calculation 3. Setup 4. Delivery Uniform phantoms and dosimeters Standardized analysis Uniform pass/fail criteria Allows inst. to inst. comparison Phantom Patient Patient Phantom

RPC Phantoms Pelvis (10) Thorax (10) Spine (8) H&N (30) Liver (6) SRS Head (10)

RPC Phantoms for Protons prostate phantom lung phantom head phantom spine phantom

Phantom Irradiations per Year

Measurement vs. Monte Carlo Criteria 3%/2 mm 0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2.0 L R LATERAL L P Axial Varian 6 MV IMRT H&N 21

Lung Phantom TLD results 1.10 1.08 1.06 1.04 TLD results Irradiation Lung Phantom Average = 0.967 +/- 2.9% 274 irradiations Algorithms included: AAA/Superposition/MonteCarlo RPC/Inst 1.02 1.00 0.98 0.96 0.94 0.92 0.90 0 50 100 150 200 250 Irradiation

Lung Phantom TLD results 1.10 1.08 1.06 Average = 0.994 +/- 3.3% 30 irradiations Algorithms included: MonteCarlo TLD results Irradiation Lung Phantom Average = 0.967 +/- 2.9% 274 irradiations Algorithms included: AAA/Superposition/MonteCarlo 1.04 RPC/Inst 1.02 1.00 0.98 0.96 0.94 0.92 0.90 0 50 100 150 200 250 Irradiation

Percent of pixels passing 5%/3mm gamma criteria Percent of pixels passing ±5%/3mm criteria 100 80 60 40 20 0 96 90 50 86 52 85 94 31 61 Pinnacle SC Eclipse AAA Eclipse PB XiO SC XiO Clarkson TomoTherapy SC MultiPlan MC MultiPlan PB Corvus PB

Phantom Accomplishments Setting a standard for IMRT use in national and international clinical trials Use of heterogeneity corrections for modern algorithms Test ability to hit a moving target(s) Provide consistent and independent QA evaluation tool Testing proton therapy planning and dose calculations

Phantom Results Comparison between institution s plan and delivered dose. Phantom H&N Prostate Spine Lung Irradiations 1368 419 176 664 Pass 1135 686 (83%) (79%) 359 162 (86%) (82%) 119 22 (68%) (63%) 535 17(75%) (81%) Fail 233 187 61 35 5713 129 59 Criteria 7%/4mm 7%/4mm 5%/3mm 5%/5mm

Phantom Statistics

Progress is being Made!

Use of Advanced Technologies in clinical trials?

Pay Attention to the Basics as well

Thoughts to Consider The goal in radiotherapy is to achieve the golden ±5% dose delivery goal for our patients. Realistically I believe that there are many good RT sites that deliver well within 5%, but there are many that probably, for some patients, are somewhere between 5-10%. Primary reasons Human error Don t understand the complex processes Don t pay attention to QA results Resources

Be Willing to Consider an Independent Audit 1. Local physicist at another RT center 2. Physicist at your center/physics group 3. Consulting physicists 4. Former medical physics classmates 5. Radiological Physics Center

Conclusions 1. Take more time and ask questions. 2. Reread the task group report. 3. Read the clinical trial protocol. 4. Be willing to admit you were wrong and learn from your mistakes. 5. Place more responsibility on manufacturers to implement more accurate systems. 6. MLC QA! 7. Use only the most recent heterogeneity correction algorithms (preferably Monte Carlo or Acuros XB). 8. Small field dosimetry caution, how small can we really go? 9. Implement IGRT for heaven s sake. 10. Be inquisitive, don t just believe others at face value.